In vivo neutralization of murine CXCR2 (as compared with treatment with control antibodies) attenuates lung neutrophil sequestration as determined by MPO levels from mice placed on a high–peak pressure/stretch ventilator protocol (n = 10 mice per group). *P < 0.05.